Back to top
more

Avinger (AVGR)

(Delayed Data from NSDQ)

$3.74 USD

3.74
5,874

-0.03 (-0.80%)

Updated Apr 30, 2024 03:17 PM ET

After-Market: $3.84 +0.10 (2.67%) 5:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 46% (136 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Sanghamitra Saha headshot

Bet on Rising P/E Investing With These Top 5 Stocks

by Sanghamitra Saha

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Avinger (AVGR) Upgraded to Buy: Here's Why

by Zacks Equity Research

Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys

by Zacks Equity Research

Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys

Sanghamitra Saha headshot

What Bargain Hunting? Tap 5 Stocks With Rising P/E

by Sanghamitra Saha

Bet on these top-ranked stocks with rising P/E for outsized gains.

Sanghamitra Saha headshot

Try Rising P/E Investing With 5 Top-Ranked Stocks

by Sanghamitra Saha

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Avinger (AVGR) Upgraded to Strong Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Top Ranked Momentum Stocks to Buy for October 24th

by Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 24th.

Sanghamitra Saha headshot

Go Beyond Bargains: Play 5 Stocks With Rising P/E Instead

by Sanghamitra Saha

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Is Avinger (AVGR) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (AVGR) Outperforming Other Medical Stocks This Year?

Is Avinger (AVGR) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (AVGR) Outperforming Other Medical Stocks This Year?

Avinger (AVGR) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Avinger (AVGR) closed at $0.58 in the latest trading session, marking a -0.62% move from the prior day.

Top Ranked Momentum Stocks to Buy for April 11th

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 11th.

EDAP TMS (EDAP) Looks Good: Stock Adds 7.9% in Session

by Zacks Equity Research

EDAP TMS (EDAP) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Top Ranked Momentum Stocks to Buy for April 9th

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 9th:

Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger

by Zacks Equity Research

Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger

Sanghamitra Saha headshot

What Bargain Hunting? Tap 5 Stocks With Rising P/E

by Sanghamitra Saha

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

Sanghamitra Saha headshot

What Bargain Hunting? Tap 5 Stocks With Rising P/E

by Sanghamitra Saha

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

Sanghamitra Saha headshot

5 Top Rising P/E Stocks to Enjoy Solid Gains

by Sanghamitra Saha

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals

by Zacks Equity Research

Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals

Sanghamitra Saha headshot

5 Top-Ranked Rising P/E Stocks to Lure Investors

by Sanghamitra Saha

Inside the top-ranked stocks that have been exhibiting rising P/E ratios.

    Align Technology (ALGN) Beats on Q1 Earnings and Revenues

    by Zacks Equity Research

    Align Technology Inc. (ALGN) reported adjusted earnings per share (EPS) of 85 cents in the first quarter of 2017, up 70% from 50 cents posted in the year-ago quarter.

      Cerner (CERN) Earnings and Revenues Beat Estimates in Q1

      by Zacks Equity Research

      Cerner Corp (CERN) reported adjusted first-quarter 2017 earnings of 56 cents per share, beating the Zacks Consensus Estimate of 53 cents.

        CONMED (CNMD) Q1 Earnings Surpass Estimates, Increase Y/Y

        by Zacks Equity Research

        CONMED Corporation (CNMD) reported first-quarter 2017 adjusted earnings of 38 cents per share, beating the Zacks Consensus Estimate by 4 cents.

          Stryker (SYK) Earnings and Revenues Beat Estimates in Q1

          by Zacks Equity Research

          Stryker Corp (SYK) reported adjusted earnings of $1.48 per share in the first quarter of 2017, which comfortably beat the Zacks Consensus Estimate by 5 cents.

            Centene (CNC) Beats Q1 Earnings on HealthNet Acquisition

            by Zacks Equity Research

            Centene Inc. (CNC) reported first-quarter 2017 adjusted net income per share of $1.12 cents, which beat the Zacks Consensus Estimate by 5.7%.